Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
97 studies found for:    heart transplant OR cardiac transplant | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Study of Heart Transplant Rejection
Condition: Heart Transplantation
Intervention:
2 Unknown  Fish Oil In Heart Transplantation
Condition: Myocardial Tissue in Heart Transplantation
Intervention: Dietary Supplement: Fish Oil
3 Not yet recruiting Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Conditions: Heart Transplant;   Liver Transplant;   Small Intestine Transplant;   Lymphoproliferative Disorders;   Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder
Intervention:
4 Recruiting Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring
Conditions: Cardiovascular Disease;   Acute Rejection of Cardiac Transplant;   Cardiac Transplant Rejection;   Heart Transplant Failure and Rejection
Intervention:
5 Recruiting Home Electrocardiogram (ECG) Monitoring After Heart Transplantation
Conditions: Cardiac Transplant Rejection;   Qt Interval, Variation in
Intervention:
6 Recruiting Pediatric Heart Transplantation: Transitioning to Adult Care
Condition: Heart Transplantation
Intervention: Behavioral: TRANSIT
7 Recruiting Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Condition: Congestive Heart Failure
Intervention:
8 Unknown  Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation
Condition: Heart Transplant
Intervention:
9 Recruiting Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study
Condition: Cardiac Transplantation
Intervention:
10 Recruiting Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
Conditions: Advanced Heart Failure;   Systolic Heart Failure
Intervention: Other: No Intervention
11 Recruiting HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Other: None - this is an observational study
12 Not yet recruiting Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
Conditions: Dilated Cardiomyopathy (DCM);   Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy;   Heart Failure
Intervention: Biological: Allogeneic Cardiosphere-Derived Cells (CDCs)
13 Recruiting The Randomized Evaluation of VAD InterVEntion Before Inotropic Therapy
Condition: Congestive Heart Failure
Interventions: Device: HM II® (HeartMate II® LVAD);   Other: OMM (Optimal Medical Management)
14 Recruiting PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Procedure: Transendocardial injection;   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs
15 Recruiting Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant
Conditions: Cancer Survivor;   Diabetes Mellitus;   Hypertension
Interventions: Procedure: computed tomography;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: questionnaire administration
16 Recruiting Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy
Conditions: Liver Transplantation;   Kidney Transplantation
Intervention: Drug: rTPA Treatment
17 Recruiting Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Conditions: Graft vs Leukemia;   Graft vs Host Disease
Intervention:
18 Recruiting Scleroderma Treatment With Autologous Transplant (STAT) Study
Condition: Systemic Scleroderma
Interventions: Procedure: peripheral blood stem cell transplantation;   Drug: cyclophosphamide;   Biological: anti-thymocyte globulin;   Other: questionnaire administration;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Biological: filgrastim;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: mycophenolate mofetil;   Drug: plerixafor
19 Recruiting Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia;   Diamond-Blackfan Anemia
Interventions: Procedure: Radiotherapy;   Drug: Alemtuzumab (Campath  );   Drug: Sirolimus (Rapamune  )
20 Not yet recruiting B Cell Induction in Pediatric Lung Transplantation
Conditions: Heart / Lung Transplant;   Lung Transplant
Interventions: Biological: Rituximab (Rituxan®);   Biological: Placebo for Rituximab (Rituxan®)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years